Slingshot members are tracking this event:

Pfizer (PFE) Expects Decision From European Medicines Agency on IBRANCE + Endocrine Therapy for HR+/HER2- Metastatic Breast Cancer By End of November

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Additional Information

Management Comment Press Release
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords European Medicines Agency, Ibrance, Endocrine Therapy, Hr+/her2- Metastatic Breast Cancer